Lemonade's downside risks are diminishing, and the potential for the company to thrive is increasing. Read why I remain ...

Up-and-coming insurance company Lemonade (NYSE: LMND) is trying to disrupt insurance by putting its spin on the industry.

Jason Hall has positions in Lemonade and has the following options: short November 2024 $39 calls on Lemonade. The Motley ...

Fintech stocks continued to post the largest gains among financials this past week as the crypto market continues to expect a ...

Lemonade stock price has gone parabolic, soaring for four consecutive weeks and reaching its highest level since December ...

In 2025, we can expect to see a convergence of several key trends that prioritize holistic health and personalized ...

JMP Securities raised the firm’s price target on Lemonade (LMND) to $60 from $40 and keeps an Outperform rating on the shares. Lemonade’s investor day event drove home how the company is well ahead of ...

We’re all familiar with the concept of false advertising these days. But you might not always expect this behavior from a ...

Piper Sandler raised the firm’s price target on Lemonade (LMND) to $44 from $25 and keeps a Neutral rating on the shares after participating in the company’s well-attended investor day in New ...

BMO Capital raised the firm’s price target on Lemonade (LMND) to $15 from $13 and keeps an Underperform rating on the shares following ...

That’s from the Al Copeland Foundation. You jump the line, get a t-shirt and a cup of Josh’s lemonade. And most of us all, ...